Northwell Health: Lupus Erythematosus, Systemic trials

The registry lists 10 Lupus Erythematosus, Systemic studies with Northwell Health as lead sponsor. 3 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 3Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Transcutaneous Vagus Nerve Stimulation in SLERecruitingNCT06987565Phase 2
• Electroencephalogram Recording in Patients With Systemic Lupus ErythematosusRecruitingNCT06378736
• Trial of Belimumab in Early LupusRecruitingNCT03543839Phase 4
• Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal PainCompletedNCT02822989Not applicableResults posted
• Nelfinavir in Systemic Lupus ErythematosusTerminatedNCT02066311Phase 2Results posted
• Centrally Acting ACE Inhibition in SLEActive, not recruitingNCT04486118Phase 2
• 3,3'-Diindolylmethane in Patients With Systemic Lupus ErythematosusTerminatedNCT02483624Phase 1
• Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus ErythematosusCompletedNCT02456168
• The Role of ITGAM in Systemic Lupus ErythematosusCompletedNCT01230112
• Autoimmunity in Sisters of Lupus PatientsCompletedNCT01076101